NanoString Technologies Inc (NSTG)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

530 FAIRVIEW AVENUE NORTH SEATTLE, WA 98109

NanoString Technologies, Inc. engages in the development, manufacture, and sale instruments and consumables for use in life sciences research applications. The company provides nCounter Analysis System, an automated, multi-application, digital detection, and counting system that includes nCounter Prep Station, an automated liquid handling component for processing and preparing the samples for data collection; and nCounter Digital Analyzer, which collects data from samples through the images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. Its nCounter Analysis System supports research and the development of future clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, a data analysis program that offers nCounter Analysis System users the ability to quality check, normalize, and analyze their data. In addition, it provides gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits, and human karyotype panels; custom CodeSets; and master kits that are ancillary reagents, cartridges, tips, and reagent plates to setup and process samples in its instruments. Further, the company plans to develop and sell diagnostic kits for use in molecular diagnostic testing in clinical laboratories. It markets its systems and related consumables to researchers in academic, government, and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of disease in North America, Europe, the Middle East, and the Asia Pacific.

Data based on most recent fiscal year report
Market Cap187.304 Million Shares Outstanding25.38 Million Avg Volume331.779 Thousand
1-Yr BETA vs S&P TR1.027 Current Ratio3.39 Quick Ratio2.84
View SEC Filings from NSTG instead.
Q1 2019 All Institutions Hedge Funds 1
To trade NSTG now:
Filers who had this stock in their top 10: 2 1 (0.1%)
13F Filers holding this stock: 135 36 (3.67%)
Aggregate 13F shares on 03/31/2019: 32.892 Million 7.051 Million
Aggregate 13F shares on 12/31/2018: 27.332 Million 7.328 Million
Percent change: 20.34% -3.79%
Funds creating new positions: 46 15
Funds Adding to an existing position: 53 13
Funds closing out their position: 6 5
Funds reducing their position: 27 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NSTG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

2.1 Million total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FINNEY ELISHA W

  • Director
1,895 2019-05-15 1

GRAY R BRADLEY PRESIDENT AND CEO

  • Officer
  • Director
26,530 2019-05-13 9

WAITE CHARLES P JR

  • Director
0 2019-03-25 1

BEECHEM JOSEPH M SVP, RESEARCH & DEVELOPMENT

  • Officer
0 2019-03-25 6

GALAKATOS NICHOLAS

  • Director
  • 10% Owner
0 2019-03-25 2

NORDEN GREGORY

  • Director
0 2019-03-25 1

YOUNG WILLIAM

  • Director
0 2019-03-25 1

GHESQUIERE DAVID W. SVP, CORPORATE & BUSINESS DEV

  • Officer
0 2019-03-25 7

HERSHBERG ROBERT

  • Director
0 2019-03-25 1

MALLOY KIRK

  • Director
0 2019-03-25 1

ALLEN MARY TEDD SVP, OPERATIONS

  • Officer
0 2019-03-25 12

BROWN J. CHAD SVP, SALES & MARKETING

  • Officer
0 2019-03-25 4

BAILEY K THOMAS CHIEF FINANCIAL OFFICER

  • Officer
0 2019-03-25 1

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

BLACKSTONE CLARUS II L.L.C.

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE HOLDINGS I/II GP INC

BLACKSTONE GROUP L.P.

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
2,036,025 2019-03-22 2

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE CLARUS II L.L.C.

BLACKSTONE HOLDINGS I/II GP INC

BLACKSTONE GROUP L.P.

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
4,036,025 2019-01-04 1

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

  • 10% Owner
4,036,025 2018-09-17 2

JOHNSON JAMES A CHIEF FINANCIAL OFFICER

  • Officer
8,548 2017-09-01 0

BURNS WAYNE SVP, OPERATIONS & ADMIN

  • Officer
74,565 2017-03-01 0

SAUNDERS BARNEY SVP, SALES & MARKETING

  • Officer
4,664 2017-03-01 0

OVP VENTURE PARTNERS VI LP

OVP VENTURE PARTNERS VII LP

OVP VI ENTREPRENEURS FUND LP

OVP VII ENTREPRENEURS FUND LP

  • 10% Owner
No longer subject to file 2014-09-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GRAY R BRADLEY - Director - Officer PRESIDENT AND CEO

2019-05-13 S 39,919 $26.38 d 36,611 26,530.00 direct yes

GRAY R BRADLEY - Director - Officer PRESIDENT AND CEO

2019-05-13 S 2,994 $28.18 d 26,530 26,530.00 direct yes

GRAY R BRADLEY - Director - Officer PRESIDENT AND CEO

2019-05-13 S 7,087 $27.09 d 29,524 26,530.00 direct yes

BAILEY K THOMAS - Officer CHIEF FINANCIAL OFFICER

2019-03-25 A 16,129 a 16,129 0.00 direct

ALLEN MARY TEDD - Officer SVP, OPERATIONS

2019-03-25 A 18,023 a 18,023 0.00 direct

BEECHEM JOSEPH M - Officer SVP, RESEARCH & DEVELOPMENT

2019-03-25 A 16,129 a 16,129 0.00 direct

MALLOY KIRK - Director

2019-03-25 A 4,410 a 4,410 0.00 direct

GHESQUIERE DAVID W. - Officer SVP, CORPORATE & BUSINESS DEV

2019-03-25 A 18,023 a 18,023 0.00 direct

GRAY R BRADLEY - Director - Officer PRESIDENT AND CEO

2019-03-25 A 124,778 a 124,778 0.00 direct

NORDEN GREGORY - Director

2019-03-25 A 4,410 a 4,410 0.00 direct

BAILEY K THOMAS - Officer CHIEF FINANCIAL OFFICER

2019-03-25 A 30,501 a 30,501 0.00 direct

BROWN J. CHAD - Officer SVP, SALES & MARKETING

2019-03-25 A 16,129 a 16,129 0.00 direct

BEECHEM JOSEPH M - Officer SVP, RESEARCH & DEVELOPMENT

2019-03-25 A 30,501 a 30,501 0.00 direct

HERSHBERG ROBERT - Director

2019-03-25 A 4,410 a 4,410 0.00 direct

GALAKATOS NICHOLAS - Director - > 10% Owner

2019-03-25 A 4,410 a 4,410 0.00 direct

YOUNG WILLIAM - Director

2019-03-25 A 4,410 a 4,410 0.00 direct

WAITE CHARLES P JR - Director

2019-03-25 A 4,410 a 4,410 0.00 direct

ALLEN MARY TEDD - Officer SVP, OPERATIONS

2019-03-25 A 9,531 a 9,531 0.00 direct

BROWN J. CHAD - Officer SVP, SALES & MARKETING

2019-03-25 A 30,501 a 30,501 0.00 direct

FINNEY ELISHA W - Director

2019-03-25 A 4,410 a 4,410 0.00 direct

GHESQUIERE DAVID W. - Officer SVP, CORPORATE & BUSINESS DEV

2019-03-25 A 9,531 a 9,531 0.00 direct

GRAY R BRADLEY - Director - Officer PRESIDENT AND CEO

2019-03-25 A 65,982 a 65,982 0.00 direct

CLARUS LIFESCIENCES II, L.P. - > 10% Owner see footnotes

CLARUS VENTURES II GP, L.P. - > 10% Owner see footnotes

BLACKSTONE CLARUS II L.L.C. - > 10% Owner see footnotes

BLACKSTONE HOLDINGS II L.P. - > 10% Owner see footnotes

BLACKSTONE HOLDINGS I/II GP INC - > 10% Owner see footnotes

BLACKSTONE GROUP L.P. - > 10% Owner see footnotes

BLACKSTONE GROUP MANAGEMENT L.L.C. - > 10% Owner see footnotes

SCHWARZMAN STEPHEN A - > 10% Owner see footnotes

2019-03-22 S 2,000,000 $21.62 d 2,036,025 2,036,025.00 indirect
Click here to report any possible errors with this stock listing.

Elevate your investments